After earning doctorate degree in Biotechnology from University of Alabama in Huntsville followed by post doctoral fellowship in HIV Virology from Children’s Hospital in Los Angeles, Namritha joined Thermo Fisher Scientific in 2008.  During her early years at Thermo Fisher Scientific, Namritha led several custom service offerings including cDNA library synthesis, RNAi screening, virus production and cell engineering. Following that, she led a product development team focused on gene editing and modulation tools, specifically Cas9 DNA and mRNA systems, CRISPR libraries and lncRNAi. In her current role, Namritha manages R&D team dedicated to developing closed automated instrument platforms to address cell processing, gene delivery and cell engineering needs within cell and gene therapy manufacturing workflow.